No Data
Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
PDF VersionSAN DIEGO--(BUSINESS WIRE)--Jul. 11, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2024
Glaukos Cut as Citi Reviews U.S. MedTechs
Citi Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $57
Citi analyst Joanne Wuensch maintains $Tandem Diabetes Care(TNDM.US)$ with a buy rating, and maintains the target price at $57.According to TipRanks data, the analyst has a success rate of 60.7% and
Understanding Tandem Diabetes Care: Joanne Wuensch's Investment Perspective
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones index surging around 200 points on Monday.Shares of Corning Incorporated (NYSE:GLW) rose sharply during Monday's session after the company increased its sec
Stifel Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $60
Stifel analyst Mathew Blackman maintains $Tandem Diabetes Care(TNDM.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success rate of 47.9% an